• SENSEX
    NIFTY 50
Healthcare

R Ananthanarayanan new MD and CEO of Strides Pharma

Updated : January 08, 2020 09:52 PM IST

He will succeed Arun Kumar, founder and the incumbent CEO and MD of the company, Strides Pharma Science said in a statement.
Ananth brings with him over three decades of top global pharmaceutical experience across both the technical and commercial functions, the statement said.
Until recently, Ananth was the global chief operating officer at Cipla, where he was responsible for the company's generics business in regulated markets.
R Ananthanarayanan new MD and CEO of Strides Pharma

You May Also Like

Live TV
Advertisement